Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Company research

Rothe Development, Inc.

CIK 2108671Updated Sep 27, 2026

No exchange listing on record for this SEC filer. Coverage is drawn from its filings.

Filing activity

SEC EDGAR
Latest filing

S-1/A · Sep 21, 2026

2 filings on record · S-1/A, S-1.

About the company

We are a recognized leader in astronaut training and mission operations support through our role at NASA’s Neutral Buoyancy Laboratory (“NBL”), the world’s premier facility for astronaut extravehicular activity (“EVA”) training and mission simulation supporting International Space Station (“ISS”) and Artemis missions. For more than 50 years, we have also supported the commercialization of NASA facilities and capabilities through the NBL, enabling commercial aerospace, defense, robotics, energy, and subsea technology organizations to access specialized testing, training, and operational environments.

S-1/A · 2026-09-21 · 0001493152-26-043509

Company description from the cited filing.

Recent filings

  1. S-1/A filing

    S-1/A · 2026-09-21 · 0001493152-26-043509

  2. S-1 filing

    S-1 · 2026-09-04 · 0001493152-26-041590

Offerings

Registration 333-298788

S-1/A · 2026-09-21 · 0001493152-26-043509

Terms from the governing filing for this registration; not a claim that the offering is open today.

Filing attachments

ex107.htm · S-1 · 2026-09-04

Calculation of Filing Fee Tables S-1 Rothe Development, Inc. ──────────────────────────────────── Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable ─────────────────────────────────────────────────────────────────────────────── Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum A…

S-1 · 2026-09-04 · 0001493152-26-041590

Read attachment ↗